Phase IB Trial of Induction Nivolumab or Nivolumab/Ipilimumab Prior to Concurrent Chemoradiation Plus Nivolumab in Patients With Operable Stage II/III Esophageal/ Gastroesophageal Junction Cancer
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Carboplatin; Paclitaxel
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 12 Jun 2017 Status changed from not yet recruiting to recruiting.
- 20 Mar 2017 Planned initiation date changed from 1 Feb 2017 to 1 Apr 2017.
- 09 Feb 2017 New trial record